Reuters logo
BRIEF-Bioverativ to acquire True North Therapeutics
2017年5月23日 / 上午11点17分 / 6 个月前

BRIEF-Bioverativ to acquire True North Therapeutics

May 23 (Reuters) - Bioverativ Inc-

* Bioverativ to acquire clinical-stage rare disease biotechnology company, True North Therapeutics

* Bioverativ Inc - deal for for an upfront payment of $400 million plus assumed cash

* Bioverativ Inc - true north investors are also eligible to receive additional payments of up to $425 million contingent on achievement of future milestones

* Says the acquisition will be financed through a combination of cash on hand and debt

* Bioverativ Inc says has entered into a definitive agreement to acquire south san francisco-based true north therapeutics Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below